Insider · CIK 0001615726

Van der Ploeg Leonardus H.T.

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001615726

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-05-31	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	$4.59	+$23K	47,339
2019-05-31	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−5,000 sh	$25.10	−$126K	42,339
2019-05-31	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	—	—	8,611
2019-05-30	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	$4.59	+$23K	47,339
2019-05-30	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−5,000 sh	$25.31	−$127K	42,339
2019-05-30	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	—	—	13,611
2019-05-29	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	$4.59	+$23K	47,339
2019-05-29	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−5,000 sh	$25.51	−$128K	42,339
2019-05-29	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	—	—	18,611
2019-05-28	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+9,860 sh	$4.59	+$45.3K	52,199
2019-05-28	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+140 sh	$6.14	+$859.6	52,339
2019-05-28	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−10K sh	$25.38	−$254K	42,339
2019-05-28	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+9,860 sh	—	—	23,611
2019-05-28	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+140 sh	—	—	55,290
2019-02-13	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+70K sh	—	—	70,000
2019-01-16	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−200 sh	$30.00	−$6,000	42,339
2018-11-02	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+8,200 sh	$4.59	+$37.6K	60,539
2018-11-02	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$6.14	+$61.4K	70,539
2018-11-02	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$7.52	+$75.2K	80,539
2018-11-02	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−38K sh	$30.09	−$1.14M	42,539
2018-11-02	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−8,200 sh	—	—	33,471
2018-11-02	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	55,430
2018-11-02	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	30,894
2018-09-25	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+21.8K sh	$4.59	+$100K	84,139
2018-09-25	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−3,686 sh	$27.45	−$101K	80,453
2018-09-25	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−9,052 sh	$28.88	−$261K	71,401
2018-09-25	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−7,656 sh	$29.81	−$228K	63,745
2018-09-25	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−5,304 sh	$30.60	−$162K	58,441
2018-09-25	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−6,102 sh	$31.86	−$194K	52,339
2018-09-25	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−21.8K sh	—	—	41,671
2018-06-29	RYTMRHYTHM PHARMACEUTICALS, INC.G Gift	Chief Scientific Officer	GGift	−2,000 sh	—	—	62,339
2018-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+55K sh	—	—	55,000

Recent filings

Accepted (ET)
Jun 34
Van der Ploeg Leonardus H.T.0001104659-19-033437
SEC(opens sec.gov)
May 304
Van der Ploeg Leonardus H.T.0001104659-19-032725
SEC(opens sec.gov)
Feb 154
Van der Ploeg Leonardus H.T.0001104659-19-009040
SEC(opens sec.gov)
Jan 184
Van der Ploeg Leonardus H.T.0001104659-19-002494
SEC(opens sec.gov)
Nov 64
Van der Ploeg Leonardus H.T.0001104659-18-066381
SEC(opens sec.gov)

Companies

RHYTHM PHARMACEUTICALS, INC.Chief Scientific OfficerRYTM

Address

500 BOYLSTON STREET, 11TH FLOOR

BOSTON, MA, 02116